PS

Phulel Singh

Active Director Director DIN 08682258
DIN 08682258 First appointment Jan 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Phulel Singh

Data last updated:

Phulel Singh is a Director at Neoxis Healthcare Private Limited (since 2020). The company operates in Chemicals. Neoxis Healthcare Private Limited reported revenue of ₹31.3 Lakh (FY 2023).

DIN 08682258
Primary Designation Director
Industry Chemicals
First Appointment 29 Jan 2020
Oldest Company Age 7 yrs
Largest company Neoxis Healthcare Private Limited · ₹31.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neoxis Healthcare Private Limited U24232PN2019PTC187206
Director29 Jan 20202019₹31.3 Lakh (FY 2023)Active

Board colleagues of Phulel Singh

Directorship timeline

Open interactive timeline →
Neoxis Healthcare Private Limited
Premium access

Shareholding and investment profile for Phulel Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Phulel Singh

Phulel Singh currently holds 1 directorship: Neoxis Healthcare Private Limited (Director, since 29 Jan 2020, revenue ₹31.3 Lakh (FY 2023)).

Phulel Singh was first appointed on 29 Jan 2020 as Director at Neoxis Healthcare Private Limited.

The current boards of Phulel Singh's companies include Rajendra Kumar (Neoxis Healthcare Private Limited), Veerendra Singh Dhaked (Neoxis Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available